ClinicalTrials.Veeva

Menu

DMSO-PDT of BCC - A 6 Year Follow up

N

Norwegian University of Science and Technology

Status

Completed

Conditions

Carcinoma, Basal Cell

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Enrollment

44 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • histological verified bcc.
  • one or two PDT treatments with treatment interval no longer than two weeks.
  • lesion complete response three months after therapy.

Exclusion criteria

  • pregnant.
  • Gorlin's syndrome.
  • morpheaform or pigmented bcc.
  • histology older than one year.
  • tumour infiltration more than four mm.
  • previous PDT treated lesions.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems